Biotechnology Expert Group
Chair
Lisa Zannoni
Secretariat Lead
Maylis Berviller
Policy Manager
Vice-Chair
Dirk Carrez
Clever Consult
(Belgium)
Vice-Chair
Alessandra Salamini
Bayer
(United States)
Vice-Chair
Khaoula Belhaj Fragnière
International Seed Federation
(Switzerland)
-
01.
Why OECD Work on Biotechnology Policy Matters
The OECD serves its members as a forum on the regulation of modern biotechnology, including novel foods and feeds. As part of its Chemicals program, the Organization fosters a mutual understanding of regulations, facilitates harmonization of risk and safety assessments, and promotes the safe use of modern biotechnology products. Further, the OECD explores policies to encouraging innovation in emerging technology such as synthetic biology.
-
03.
How Business Engages with the OECD on Biotechnology Policy
Our Biotechnology Expert Group fosters private sector participation to the wide range of OECD biotechnology–related projects, including industrial biotechnology, human health–related biotechnology, the harmonization of regulatory oversight for the products of modern biotechnology, and international harmonization in the safety assessments of novel foods and feeds. Through the Biotechnology Expert Group, business contributes to both technical and strategic discussions on the various applications of biotechnology.
-
02.
Our 2024 Priorities
- Harmonization of global regulatory oversight
- Improving efficiency of safety assessments requirements
- Supporting policies ensuring the safety of novel foods and feeds
- Promoting innovation for sustainable bio–economies
- Fostering the development of emerging technologies for health
-
04.
Our Engagement with OECD Bodies
- OECD Chemicals and Biotechnology Committee
- OECD Working Party on the Harmonization of Regulatory Oversight in Biotechnology
- OECD Working Party on the Safety of Novel Foods and Feeds
- OECD Working Party on Biotechnology, Nanotechnology and Converging Technologies